Skip to content. | Skip to navigation

Personal tools


Managing bodies

logo Inserm      logo cnrslogo ENSL       logo ucb1

Secondary managing bodies

logo ENSL logo ucb1

You are here: Home / Teams / Dutartre H/Journo C - OR / Team presentation

Team presentation

Oncogenèse induite par le rétrovirus HTLV-1 : mécanismes moléculaires et interactions avec l'immunité innée

Research themes in the team - an overview


According to the WHO, approximately 15% of human cancers are linked to an infectious etiology. Among virus-induced cancers, adult T-cell leukemia (ATL) is one the the most aggressive blood cancers: the median survival time does not exceed 6 months in the acute forms. This pathology is caused by a retrovirus discovered in 1982 and named human T-cell leukemia virus type 1 (HTLV-1). HTLV-1 is also the causative agent of the tropical spastic paraparesis, a neuroinflammatory disease. In HTLV-1-infected individuals, the long clinical latency prior to ATL onset (several decades) suggests that retroviral oncogenesis is a multi-step process, which our lab aims at understanding.

Our research themes are at the interface of virology, immunology and cancer cell biology, and involve approaches ranging from molecular and structural biology, biochemistry, proteomics, to cell biology and pharmacology.

We also benefit from a cohort of non-human primates naturally infected by STLV-1, the simian equivalent of HTLV-1 (in collaboration with the Station of Primatology of Rousset-sur-Arc), as well as from human samples (in collaboration with Pr Hermine, Necker Hospital, Paris, and the Dr Casseb, University of São Paulo, Brazil).

We develop three main research axes (see the “Projects and grants” section for additional details):

  • Characterizing the mode of action of the viral oncoprotein Tax from HTLV-1.
  • Investigating the interactions between HTLV-1 and the innate immune system.
  • Viral transmission and identifying and testing new inhibitors of viral replication.